Skip to main content
logo
Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.43
+0.07 (1.31%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Atea Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
436279283254401743
Market Cap Growth
56.80%-1.43%11.19%-36.48%-46.08%-78.48%
Enterprise Value
216-49-198-338-261-96
Last Close Price
5.433.573.353.054.818.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----6.13
Forward PE
-4.424.424.424.424.42
PS Ratio
-----2.11
PB Ratio
2.131.010.650.460.631.05
P/TBV Ratio
2.131.010.650.460.631.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.010
Debt / EBITDA Ratio
-----0.00
Net Debt / Equity Ratio
-1.07-1.09-1.03-1.04-1.00-1.08
Net Debt / EBITDA Ratio
1.201.683.444.795.81-5.52
Net Debt / FCF Ratio
1.442.283.346.745.248.78
Asset Turnover
-----0.43
Quick Ratio
7.807.5924.4418.0435.0013.44
Current Ratio
8.137.8224.8518.2435.7713.58
Return on Equity (ROE)
-58.14%-44.34%-33.88%-22.74%-17.16%19.27%
Return on Assets (ROA)
-36.72%-28.75%-15.60%-11.94%-9.65%10.57%
Return on Capital Employed (ROCE)
-89.80%-65.10%-29.60%-21.40%-17.10%19.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-37.95%-56.77%-59.51%-53.42%-28.93%16.31%
FCF Yield
-34.92%-47.34%-47.89%-33.56%-30.68%-11.71%
Buyback Yield / Dilution
6.62%3.29%-1.05%-0.17%5.67%-308.70%
SEC Filings: 10-K · 10-Q